REQUEST A DEMO
Total
USD $0.00
Search more companies

ANGYALFOLD TERI PATIKA Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ANGYALFOLD TERI PATIKA Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

ANGYALFOLD TERI PATIKA Bt. is an enterprise in Hungary, with the main office in Nyirmartonfalva. It operates in the Pharmacies and Drug Stores industry. The company was established on February 20, 1996. ANGYALFOLD TERI PATIKA Bt. currently employs 11 (2024) people. From the latest financial highlights, ANGYALFOLD TERI PATIKA Bt. reported a net sales revenue increase of 7.87% in 2024. Its’ total assets recorded a negative growth of 27.48%. ANGYALFOLD TERI PATIKA Bt.’s net profit margin decreased by 0.86% in 2024.

Headquarters
Jokai utca 20.
Nyirmartonfalva; Hajdu-Bihar; Postal Code: 4263

Contact Details: Purchase the ANGYALFOLD TERI PATIKA Bt. report to view the information.

Basic Information
Total Employees:
Purchase the ANGYALFOLD TERI PATIKA Bt. report to view the information.
Registered Capital:
Purchase the ANGYALFOLD TERI PATIKA Bt. report to view the information.
Financial Auditors:
Purchase the ANGYALFOLD TERI PATIKA Bt. report to view the information.
Incorporation Date:
February 20, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
VIRIDIS-PHARMA KFT.
Company Performance
Financial values in the chart are available after ANGYALFOLD TERI PATIKA Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.87%
Total operating revenue
10.25%
Operating profit (EBIT)
N/A
EBITDA
55.34%
Net Profit (Loss) for the Period
-78.8%
Total assets
-27.48%
Total equity
3.03%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.86%
Return on Equity (ROE)
-11.38%
Quick Ratio
-0.52%
Cash Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?